JFG
KYNB

Jefferies Financial Group’s Kyntra Bio KYNB Stock Holding History

Jefferies Financial Group’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-332
Closed -$22.4K – 1728
2023
Q2 		$22.4K Sell
332
-1,368
-80% -$566K ﹤0.01% 1572
2023
Q1 		$793K Buy
1,700
+100
+6% +$52.9K 0.01% 969
2022
Q4 		$641K Buy
+1,600
New +$613K ﹤0.01% 986

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jefferies Financial Group's KYNB Position: Q3 2023 in Review

Jefferies Financial Group sold out of Kyntra Bio (KYNB) in Q3 2023, closing a stake of 448 shares — an estimated $30.2K sold.

Jefferies Financial Group first reported a position in KYNB in Q1 2023 and held it in 2 quarters. The position peaked at $993K in Q1 2023. 110 funds tracked by Wall St. Rank hold KYNB as of Q3 2023.

  • Jefferies Financial Group reported no remaining Kyntra Bio position as of Q3 2023 after selling out during the quarter.
  • Jefferies Financial Group sold 448 Kyntra Bio shares in Q3 2023, an estimated $30.2K.
  • Jefferies Financial Group first reported a position in Kyntra Bio in Q1 2023 and held it in 2 quarters.
  • Jefferies Financial Group's Kyntra Bio position peaked at $993K in Q1 2023.
  • 110 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2023.

Based on Jefferies Financial Group's 13F filing for Q3 2023, filed 14 Nov 2023.